Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novartis (GB:0QLR)
LSE:0QLR
0QLR Analyst Ratings
Hold
4 Buy
7 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QLR Stock 12 Month Forecast
Average Price Target
CHF99.92
▲(11.22% Upside)
| Highest Price TargetCHF115.00 | Average Price TargetCHF99.92 | Lowest Price TargetCHF82.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
Reiterated
02/20/25
Deutsche Bank
Reiterated
02/18/25
Morgan Stanley
Initiated
02/12/25
J.P. Morgan
Reiterated
02/11/25
Goldman Sachs
Reiterated
02/11/25
DZ BANK AG
Reiterated
02/03/25
Bank of America Securities
Reiterated
02/03/25
Barclays
Reiterated
02/03/25
Jefferies
Reiterated
01/31/25
Stifel Nicolaus
CHF109
Hold
21.33%
Upside
Reiterated
01/31/25
Novartis AG: Balancing Strong Performance with Future Challenges - Hold Rating Maintained
Kepler Capital
CHF104→CHF106
Buy
17.99%
Upside
Reiterated
01/28/25
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
Berenberg Bank
CHF86
Hold
-4.27%
Downside
Reiterated
01/07/25
Berenberg Bank Sticks to Its Hold Rating for Novartis AG (NOVN)
HSBC
CHF95→CHF82
Sell
-8.73%
Downside
Downgraded
12/04/24
Novartis downgraded to Reduce from Hold at HSBCNovartis downgraded to Reduce from Hold at HSBC
Best Analysts Covering Novartis AG
Which Analyst Should I Follow If I Want to Buy GB:0QLR and Sell After:
1 Month
xxx
Success Rate
25/52 ratings generated profit
Average Return
-0.49%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 48.08% of your transactions generating a profit, with an average return of -0.49% per trade.
3 Months
xxx
Success Rate
15/22 ratings generated profit
Average Return
+3.33%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.18% of your transactions generating a profit, with an average return of +3.33% per trade.
1 Year
Success Rate
19/22 ratings generated profit
Average Return
+10.63%
reiterated a buy rating 27 days ago
Copying David Evans's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +10.63% per trade.
2 Years
xxx
Success Rate
19/22 ratings generated profit
Average Return
+13.30%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +13.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QLR Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
0
0
0
0
0
Buy
8
11
9
9
10
Hold
19
23
21
22
21
Sell
2
4
6
5
5
Strong Sell
0
0
0
0
0
total
29
38
36
36
36
Each month's total comprises the sum of three months' worth of ratings.
0QLR Financial Forecast
0QLR Stock Forecast FAQ
What is GB:0QLR’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis’s 12-month average price target is CHF99.92.
What is GB:0QLR’s upside potential, based on the analysts’ average price target?
Novartis has 11.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novartis a Buy, Sell or Hold?
Novartis has a consensus rating of Hold, which is based on 4 buy ratings, 7 hold ratings and 3 sell ratings.
What is Novartis’s share price target?
The average share price target for Novartis is CHF99.92. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF115.00 ,and the lowest forecast is CHF82.00. The average share price target represents 11.22% Increase from the current price of CHF89.84.
The highest analyst share price target is CHF115.00 ,and the lowest forecast is CHF82.00. The average share price target represents 11.22% Increase from the current price of CHF89.84.
What do analysts say about Novartis?
Novartis’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Novartis?
To buy shares of GB:0QLR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.